Evidence map›Paper›PMID 40830731›Full record

ArticleParasitology research2025

In vitro evaluation of 4,4'-trimethylenedipyridinium and 4,4'-trimethylenedipiperidinium-based polycationic polymers against Acanthamoeba hatchetti.

Tomas Rimkus, Stephan Reichl

Abstract read
In one paragraph

Article in Parasitology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tomas RimkusInstitute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Brunswick, Germany.
Stephan ReichlInstitute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Brunswick, Germany. s.reichl@tu-braunschweig.de.

Funding

Niedersächsisches Ministerium für Wissenschaft und Kultur iCA_13-01-2020
6 · The paper itself

Abstract

Corneal exposure to trophozoites of Acanthamoeba spp. may lead to Acanthamoeba keratitis (AK)-a rare, but sight-threatening disease-with a risk of recurrence due to residual stromal cysts. With polyhexanide (PHMB) and chlorhexidine (CHX) often constituting the standard regimen of therapy, polymeric compounds for the treatment of AK have shifted into the focus of research. In this study, the effectiveness of four 4,4'-trimethylenedipyridinium (TMDPy), 4,4'-trimethylenedipiperidinium (TMDPi)-based polymers, and polyquaternium-1 on Acanthamoeba trophozoites and cysts has been evaluated and their interactions with cells characterized. A total eradication assay was performed to assess the efficacy of the investigated compounds, while its effects on host cells and the barrier integrity of epithelial cell layers were evaluated via MTT assays and the relative reduction of transepithelial electrical resistance (TEER). The 4,4'-trimethylenedipyridinium and 4,4'-trimethylenedipiperidinium-based compounds exhibited a high efficacy against trophozoites (< 20 µg/mL), while the cysticidal activity proved to be considerably lower (< 500 µg/mL). The detrimental effect on viability of host cells was time-dependent, while a near total reduction of TEER was observed within the first 15 min of exposure, leading to the conclusion that this class of polymers may not be adequate for therapeutic purposes, but possibly find use as preservatives for contact lens storage solutions.

Indexed as

AcanthamoebaAntiprotozoal AgentsPolymersPyridinium CompoundsAcanthamoeba KeratitisBiguanidesCell LineEpithelial CellsHumansTrophozoitesAntiprotozoal AgentsBiguanidespolihexanidePolymerspolyquaternium 1Pyridinium CompoundsAcanthamoebaPolycationicPolymersPreservativesTrimethylenedipiperidineTrimethylenedipyridine

Identifiers

PMID40830731
PMCPMC12364755

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.